Features of the treatment of patients with chronic heart failure in combination with alcoholic liver disease
https://doi.org/10.31146/1682-8658-ecg-166-6-70-79
Abstract
The article provides a brief literature review on the problem of comorbid pathology, namely, chronic heart failure (CHF) in patients with coronary heart disease (CHD) in combination with alcoholic liver disease (ABP). The issues of epidemiology, the relationship of pathogenetic mechanisms in the development and progression of CHF and ABP are considered. The issues of optimizing the treatment of CHF and ABP are discussed in the light of current recommendations and evidence base. Of particular interest is the diagnosis of such a complication as hepatic encephalopathy (PE), the possibility of its reversibility during therapy with the inclusion of L-ornithine-L-aspartate. A clinical case of a patient suffering from heart failure due to post-infarction cardiosclerosis in combination with toxic hepatitis is given.
Keywords
хроническая сердечная недостаточность,
ишемическая болезнь сердца,
алкогольная болезнь печени,
острый токсический гепатит,
карведилол,
L-орнитин-L-аспартат,
chronic heart failure,
coronary heart disease,
alcoholic liver disease,
acute toxic hepatitis,
carvedilol,
L-ornithine-L-aspartate
About the Authors
A. G. Evdokimova
Moscow state university of medicine and dentistry named after A. I. Evdokimov
Russian Federation
L. V. Zhukolenko
Moscow state university of medicine and dentistry named after A. I. Evdokimov
Russian Federation
V. V. Evdokimov
Moscow state university of medicine and dentistry named after A. I. Evdokimov
Russian Federation
A. V. Tomova
Family Medical Center Network
Russian Federation
A. A. Golikova
Moscow state university of medicine and dentistry named after A. I. Evdokimov
Russian Federation
R. I. Stryuk
Moscow state university of medicine and dentistry named after A. I. Evdokimov
Russian Federation
For citations:
Evdokimova A.G.,
Zhukolenko L.V.,
Evdokimov V.V.,
Tomova A.V.,
Golikova A.A.,
Stryuk R.I.
Features of the treatment of patients with chronic heart failure in combination with alcoholic liver disease. Experimental and Clinical Gastroenterology. 2019;(6):70-79.
(In Russ.)
https://doi.org/10.31146/1682-8658-ecg-166-6-70-79
Views:
245